SCHEMBL20205650

SCHEMBL20205650

CC1(C)c2ccccc2-c2c1cc(-c1cc3c(c4c1oc1ccccc14)-c1cc4c(cc1C3(C)C)-c1c(cc(-c3cc5c(c6ccccc36)-c3ccccc3C5(C)C)c3oc5ccccc5c13)C4(C)C)c1ccccc21

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PGR P06401 1/20 0.33
ALOX5 P09917 2/20 0.32
ALK Q9UM73 7/20 0.31
KDM4E B2RXH2 1/20 0.31
MEN1 O00255 1/20 0.31
CYP3A4 P08684 1/20 0.31
ALPI P09923 1/20 0.31
GAA P10253 1/20 0.31
MAPT P10636 1/20 0.31
PKM P14618 1/20 0.31
HPGD P15428 1/20 0.31
CASP3 P42574 1/20 0.31
RECQL P46063 1/20 0.31
BLM P54132 1/20 0.31
CASP7 P55210 1/20 0.31
CASP6 P55212 1/20 0.31
KMT2A Q03164 1/20 0.31
MCL1 Q07820 1/20 0.31
HSD17B10 Q99714 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20205292 0.95 PGR (0.33) PGR
SCHEMBL20205653 0.92 ALOX5 (0.31) PGRALOX5
SCHEMBL20205730 0.92 ALOX5 (0.34) ALOX5CDC14BCDC14A
SCHEMBL23351972 0.90 PGR (0.36) PGRALOX5ALKMAOA
SCHEMBL20205432 0.88 ALOX5 (0.32) ALOX5
SCHEMBL20205635 0.87 PGR (0.34) PGRALKKDM4EMEN1CYP3A4
SCHEMBL22859773 0.87 CDC14B (0.38) PGRALOX5ALKKDM4EMEN1
SCHEMBL20205480 0.87 KDM4E (0.34) PGRKDM4EMEN1CYP3A4ALPI
SCHEMBL24649893 0.86 PTPRC (0.31)
SCHEMBL20205331 0.86 CDC14B (0.38) PGRALOX5ALKKDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11453680-B2 Bisbenzofuran-fused indeno[1,2-B]fluorene derivatives and related compounds as materials for organic electroluminescent devices (OLED) MERCK PATENT GMBH (DE) 2022-09-27 US disclosed
EP-3544985-B1 BISBENZOFURAN-FUSED INDENO[1,2-B]FLUORENE DERIVATIVES AND RELATED COMPOUNDS AS MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES (OLED) MERCK PATENT GMBH (DE) 2021-05-12 EP disclosed
WO-2018095940-A1 BISBENZOFURAN-FUSED INDENO[1,2-B]FLUORENE DERIVATIVES AND RELATED COMPOUNDS AS MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES (OLED) MERCK PATENT GMBH (DE) 2018-05-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11453680-B2 Bisbenzofuran-fused indeno[1,2-B]fluorene derivatives and related compounds as materials for organic electroluminescent devices (OLED) OCIAD2, OCIAD1, JUND PGR 4271/4885ALOX5 354/4885ALK 588/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.